Not finding it? Sign in to also search OpenAlex live.
-
B‐cell lymphoblastic lymphoma with cutaneous involvement and a KMT2A gene rearrangement2020 American Journal of Hematology article Medicine Acute Lymphoblastic Leukemia research Open access cited by 2 patents
Paul Geraeds Kemps, Arjen H.G. Cleven, Tom van Wezel, Ronald van Eijk, Freek J. Bot, Hendrik Veelken, +2 more
7citations -
ABS0718 AGE AS THE MAIN PREDICTOR FOR RHEUMATOID ARTHRITIS INITIAL TREATMENT: A MACHINE LEARNING ANALYSIS USING DATA FROM METEOR REGISTRY2025 Annals of the Rheumatic Diseases conference-abstract Medicine Rheumatoid Arthritis Research and Therapies Open access
David Vega‐Morales, Sytske Anne Bergstra, A Chopra, Wendy Marisol Orzúa-de la Fuente, Pedro Machado, Elsa Vieira‐Sousa, +1 more
0citations -
A randomized, double-blind, placebo-controlled 12-week trial of infliximab in patients with juvenile-onset spondyloarthritis2022 Arthritis Research & Therapy article Medicine Spondyloarthritis Studies and Treatments Open access
Rubén Burgos‐Vargas, Adalberto Loyola Sánchez, Sofía Ramiro, Arturo Reding‐Bernal, Everardo Alvarez Hernández, Désirée M F M van der Heijde, +1 more
14citations -
Allogeneic Hematopoietic Cell Transplantation for Vexas Syndrome: Results of a Multicenter Study from the Chronic Malignancies and Autoimmune Disease Working Parties of the EBMT
Carmelo Gurnari, Linda Köster, Laurien G.A. Baaij, Maël Heiblig, Ibrahim Yakoub‐Agha, Jakob Robert Passweg, +18 more
5citations -
Using the LeiCNS-PK3.0 Physiologically-Based Pharmacokinetic Model to Predict Brain Extracellular Fluid Pharmacokinetics in Mice2023 Pharmaceutical Research article Neuroscience Barrier Structure and Function Studies Open access
Mohammed A. A. Saleh, Berfin Gülave, Olivia Campagne, Clinton F. Stewart, Jeroen Elassaiss‐Schaap, Elizabeth C. M. de Lange
5citations -
Geographic Analysis of the Safety and Efficacy of Filgotinib in Rheumatoid Arthritis2022 Rheumatology and Therapy article Medicine Rheumatoid Arthritis Research and Therapies Open access
Bernard G Combe, Robin Besuyen, Antonio Gómez-Centeno, Tsukasa Matsubara, Juan José Sancho Jimenez, Zhaoyu Yin, +1 more
2citations -
DOP27 Humoral immune response after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases treated with immunosuppressive therapy - a Target to B! study2022 Journal of Crohn s and Colitis conference-abstract Medicine SARS-CoV-2 and COVID-19 Research Open access
Adriaan Volkers, Luuk Wieske, Koos P J van Dam, Maurice Steenhuis, Eileen W Stalman, Laura Y. L. Kummer, +24 more
2citations -
OP0238 IMMUNOSUPPRESSION WITH TARGETED DMARDS REDUCES MORBIDITY AND MORTALITY IN PRE-CAPILLARY PULMONARY HYPERTENSION ASSOCIATED WITH SYSTEMIC SCLEROSIS: A EUSTAR ANALYSIS
Cosimo Bruni, Lorenzo Tofani, Håvard Fretheim, Eric HACHULLA, Patricia Esmeralda Carreira, Dilia Giuggioli, +47 more
2citations -
FC060: Malignancies in Patients With Anca-Associated Vasculitis Treated within the Euvas Trials2022 Nephrology Dialysis Transplantation conference-abstract Medicine Vasculitis and related conditions Open access
Beatriz Sánchez Álamo, Laura Moi, Alfred Mahr, Zdenka Hrušková, Ingeborg M. Bajema, Carin Wallquist, +2 more
0citations -
POS1134 The keyhole limpet hemocyanin (KLH) challenge model to establish early clinical proof-of-mechanism of investigational drugs for auto-immune diseases2025 Annals of the Rheumatic Diseases conference-abstract Immunology and Microbiology Immunotoxicology and immune responses Open access
Anouk C. Meijs, Micha N. Ronner, Manon A. A. Jansen, Matthijs Moerland, Naomi B. Klarenbeek
0citations -
A randomized, double-blind, placebo-controlled 12-Week trial of Infliximab in patients with Juvenile-Onset Spondyloarthritis or Enthesitis Related Arthritis
Rubén Burgos‐Vargas, Adalberto Loyola Sánchez, Sofía Ramiro, Arturo Reding‐Bernal, Raúl Gutiérrez-Suárez, Julio Casasola-Vargas, +3 more
0citations -
P0670 Efficacy of subcutaneous guselkumab induction therapy by baseline demographics and concomitant medications in participants with moderately to severely active Crohn’s disease: Results from the phase 3 GRAVITI study2025 Journal of Crohn s and Colitis conference-abstract Medicine Inflammatory Bowel Disease Open access
Ailsa L Hart, Tadakazu Hisamatsu, Flávio Steinwurz, Geert D’Haens, Wei Yong Liu, Mobolaji Olurinde, +6 more
0citations -
P0843 Efficacy by baseline disease characteristics of subcutaneous guselkumab induction therapy in patients with moderately to severely active Crohn’s disease: Results at Week 12 from the phase 3 GRAVITI study
Geert D’Haens, Flávio Steinwurz, Ailsa L Hart, Wei Yong Liu, Mobolaji Olurinde, P Ngqawa, +5 more
0citations -
OP0334 VASODILATION REDUCES THE RISK OF NEW ONSET OF INTERSTITIAL LUNG DISEASE IN SYSTEMIC SCLEROSIS: AN ASSOCIATION STUDY FROM THE EUSTAR DATABASE2025 Annals of the Rheumatic Diseases conference-abstract Medicine Systemic Sclerosis and Related Diseases Open access
L. Petelytska, Lorenzo Tofani, E. Siegert, Elisa Zanatta, Gianluca Moroncini, C. Bergmann, +13 more
0citations -
Impact of Post-transplant cyclophosphamide (PTCy)-Based Prophylaxis in Matched Sibling Donor Allogeneic Haematopoietic Cell Transplantation for Patients with Myelodysplastic Syndrome: A Retrospective Study on Behalf of the Chronic Malignancies Working Party of the EBMT
Donal P. McLornan, María Queralt Salas, Dirk‐Jan Eikema, Linda Köster, Johan A. Maertens, Jakob Robert Passweg, +18 more
0citations